Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBIT Margin (2020 - 2025)

Sotera Health (SHC) has 6 years of EBIT Margin data on record, last reported at 35.73% in Q4 2025.

  • For Q4 2025, EBIT Margin rose 570.0% year-over-year to 35.73%; the TTM value through Dec 2025 reached 33.75%, up 671.0%, while the annual FY2025 figure was 33.75%, 671.0% up from the prior year.
  • EBIT Margin reached 35.73% in Q4 2025 per SHC's latest filing, down from 36.7% in the prior quarter.
  • Across five years, EBIT Margin topped out at 36.7% in Q3 2025 and bottomed at 15.13% in Q1 2023.
  • Average EBIT Margin over 5 years is 27.6%, with a median of 27.98% recorded in 2024.
  • The widest YoY moves for EBIT Margin: up 962bps in 2023, down -747bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 27.53% in 2021, then dropped by -13bps to 23.92% in 2022, then soared by 40bps to 33.53% in 2023, then dropped by -10bps to 30.03% in 2024, then grew by 19bps to 35.73% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 35.73% in Q4 2025, 36.7% in Q3 2025, and 33.2% in Q2 2025.